SCHEMBL10065458

SCHEMBL10065458

CN[C@@H](CCC(N)=O)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.50
ENPEP Q07075 1/20 0.50
BMP1 P13497 3/20 0.43
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
ECE1 P42892 1/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6447114 0.85 ANPEP (0.67) ANPEPENPEPBMP1GABRPGABRD
SCHEMBL24712877 0.84 ANPEP (0.41) ANPEPENPEPBMP1ALOX15BLM
SCHEMBL20342061 0.84 ANPEP (0.41) ANPEPENPEPBMP1ALOX15BLM
SCHEMBL25943328 0.82 ANPEP (0.52) ANPEPENPEPBMP1GABRPGABRD
SCHEMBL805253 0.81 ANPEP (0.41) ANPEPENPEPBMP1ECE1GABRR1
SCHEMBL13851760 0.81 ANPEP (0.41) ANPEPENPEPBMP1ECE1GABRR1
SCHEMBL17911703 0.81 ANPEP (0.41) ANPEPENPEPBMP1ECE1GABRR1
SCHEMBL16710256 0.79 ANPEP (0.44) ANPEPENPEPBMP1ALOX15BLM
SCHEMBL585119 0.78 ANPEP (0.48) ANPEPENPEPGABRR1LMNASLC22A6
SCHEMBL24839201 0.78 ANPEP (0.42) ANPEPENPEPBMP1ALOX15BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071329-A1 METHODS FOR IDENTIFYING COMPOUNDS OF INTEREST USING ENCODED LIBRARIES GLAXOSMITHKLINE LLC (US) 2012-03-22 US disclosed
US-20110251089-A1 METHODS FOR SYNTHESIS OF ENCODED LIBRARIES GLAXOSMITHKLINE (US) 2011-10-13 US disclosed
US-7989395-B2 Methods for identifying compounds of interest using encoded libraries GLAXOSMITHKLINE LLC (US) 2011-08-02 US disclosed
US-7935658-B2 Methods for synthesis of encoded libraries PRAECIS PHARMACEUTICALS, INC. (US) 2011-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251089-A1 METHODS FOR SYNTHESIS OF ENCODED LIBRARIES RNGTT, DTYMK, DUT ANPEP 372/4885ENPEP 693/4885BMP1 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.